Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chau

Showing results (21-30 of 266) with videos related to

Pageof 27
Sort By:
ESMO Open|September 19, 2020
Molecular target: pan-AKT in gastric cancerByung Woog Kang, Ian Chau
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Neoadjuvant therapy before surgical treatmentRob Glynne-Jones, Ian Chau
Current Opinion in Pharmacology|January 7, 2023
Is there still a place for radiotherapy in gastric cancer?Irene Y Chong, Ian Chau
World Journal of Gastrointestinal Oncology|August 7, 2018
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancerHazel Lote, Nicola Valeri, Ian Chau
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicineMadeleine Hewish, Ian Chau, David Cunningham
Expert Opinion on Pharmacotherapy|October 25, 2007
Capecitabine in advanced gastric cancerAlicia Okines, Ian Chau, David Cunningham
Expert Review of Hematology|November 20, 2015
Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomasBenjamin Kasenda, Andrea Kühnl, Ian Chau
Cancer Treatment Reviews|August 20, 2017
Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphomaAndrea Kühnl, David Cunningham, Ian Chau
Clinical Colorectal Cancer|June 5, 2003
Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectivesIan Chau, Samuel Chan, David Cunningham
Nature Reviews. Clinical Oncology|April 7, 2011
Targeting the human EGFR family in esophagogastric cancerAlicia Okines, David Cunningham, Ian Chau
Pageof 27

Showing results (21-30 of 266) with videos related to

Sort By:
Pageof 27
ESMO Open|September 19, 2020
Molecular target: pan-AKT in gastric cancerByung Woog Kang, Ian Chau
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]|July 29, 2015
Neoadjuvant therapy before surgical treatmentRob Glynne-Jones, Ian Chau
Current Opinion in Pharmacology|January 7, 2023
Is there still a place for radiotherapy in gastric cancer?Irene Y Chong, Ian Chau
World Journal of Gastrointestinal Oncology|August 7, 2018
HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancerHazel Lote, Nicola Valeri, Ian Chau
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicineMadeleine Hewish, Ian Chau, David Cunningham
Expert Opinion on Pharmacotherapy|October 25, 2007
Capecitabine in advanced gastric cancerAlicia Okines, Ian Chau, David Cunningham
Expert Review of Hematology|November 20, 2015
Beginning of a novel frontier: T-cell-directed immune manipulation in lymphomasBenjamin Kasenda, Andrea Kühnl, Ian Chau
Cancer Treatment Reviews|August 20, 2017
Beyond genomics - Targeting the epigenome in diffuse large B-cell lymphomaAndrea Kühnl, David Cunningham, Ian Chau
Clinical Colorectal Cancer|June 5, 2003
Overview of preoperative and postoperative therapy for colorectal cancer: the European and United States perspectivesIan Chau, Samuel Chan, David Cunningham
Nature Reviews. Clinical Oncology|April 7, 2011
Targeting the human EGFR family in esophagogastric cancerAlicia Okines, David Cunningham, Ian Chau
Pageof 27